AstraZeneca chases biosimilar Avastin drug with Japanese group

ReutersAstraZeneca chases biosimilar Avastin drug with Japanese groupReutersLONDON AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's blockbuster medicine Avastin. Its new 50/50 joint venture with ...AstraZeneca Strikes Deal to Develop Version of Roche's Avastinswissinfo.chall 4 news articles »